COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,577 Articles (22,415 medRxiv, 8,162 bioRxiv)

Most recent first Previous |  Page 887: Articles 8861-8870  | Next

High Rates of Rapid Antigen Test Positivity After 5 Days of Isolation for COVID-19
Landon, E. M., Bartlett, A. H., Marrs, R., Guenette, C., Weber, S. G., Mina, M. J.
10.1101/2022.02.01.22269931 — Posted: 2022-02-02 Discussion: Onsite
The public views of and reactions to the COVID-19 pandemic in England- a qualitative study with diverse ethnicities
McNulty, C., Sides, E., Thomas, A., Kamal, A., Syeda, R., Kaissi, A., Lecky, D., Patel, M., Campos-Matos, I., Shukla, R., Brown, C., Pareek, M., Sollars, L., Nellums, L. B., Greenway, J., Jones, L. F.
10.1101/2022.02.02.22270238 — Posted: 2022-02-02
Neutralization profile of Omicron variant convalescent individuals
Roessler, A., Knabl, L., von Laer, D., Kimpel, J.
10.1101/2022.02.01.22270263 — Posted: 2022-02-02 Discussion: Onsite
Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters
Sanchez-Montalva, A., Alvarez-Sierra, D., Martinez-Gallo, M., Perurena-Prieto, J., Arrese-Munoz, I., Ruiz-Rodriguez, J. C., Espinosa-Pereiro, J., Bosch-Nicolau, P., Martinez-Gomez, X., Anton, A., Martinez-Valle, F., Riveiro-Barciela, M., Rodriguez-Frias, F., Castellano-Escuder, P., Poyato-Canton, E., Bas-Minguet, J., Martinez-Caceres, E. M., Sanchez-Pla, A., Zurera-Egea, C., Teniente-Serra, A., Hernandez-Gonzalez, M., Pujol Borrell, R.
10.1101/2022.01.29.22270016 — Posted: 2022-02-02
Association study of HLA with the kinetics of SARS-CoV-2 spike specific IgG antibody responses to BNT162b2 mRNA vaccine
Khor, S.-S., Omae, Y., Takeuchi, J. S., Fukunaga, A., Yamamoto, S., Tanaka, A., Matsuda, K., Kimura, M., Maeda, K., Ueda, G., Mizoue, T., Ujiie, M., Mitsuya, H., Ohmagari, N., Sugiura, W., Tokunaga, K.
10.1101/2022.02.01.22270285 — Posted: 2022-02-02
Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant
de Michelena, P., Torres, I., Ramos-Garcia, A., Gosalbes, V., Ruiz, N., Sanmartin, A., Botija, P., Puojois, S., Huntley, D., Albert, E., Navarro, D.
10.1101/2022.02.02.22270295 — Posted: 2022-02-02
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants
Kislaya, I., PERALTA SANTOS, A., Borges, V., Vieira, L., Sousa, C., Ferreira, B., Pelerito, A., Gomes, J. P., Pinto Leite, P., Nunes, B.
10.1101/2022.01.31.22270200 — Posted: 2022-02-02
Spatial Growth Rate of Emerging SARS-CoV-2 Lineages in England, September 2020-December 2021
Smallman-Raynor, M. R., Cliff, A. D., The COVID-19 Genomics UK (COG-UK) Consortium
10.1101/2022.02.02.22270110 — Posted: 2022-02-02
A pseudotyped lentivirus-based assay to titer SARS-CoV-2 neutralizing antibodies in Mexico
Cruz-Cardenas, J. A., Gutierrez-Mayret, M., Lopez-Arredondo, A., Castaneda-Delgado, J. E., Rojas-Martinez, A., Garcia-Rivas, G., Enciso-Moreno, J. A., Palomares, L. A., Brunck, M. E. G.
10.1101/2022.01.27.478128 — Posted: 2022-02-02
An outbreak of SARS-CoV-2 in a public-facing office in England, 2021
Atkinson, B., van Veldhoven, K., Nicholls, I., Coldwell, M., Clarke, A., Frost, G., Atchison, C. J., Raja, A. I., Bennett, A. M., Morgan, D., Pearce, N., Fletcher, T., Brickley, E. B., Chen, Y.
10.1101/2022.01.31.22269194 — Posted: 2022-02-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).